These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23355260)

  • 1. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.
    Aoki K; Ono Y; Tabata S; Matsushita A; Ishikawa T
    Int J Hematol; 2013 Feb; 97(2):272-4. PubMed ID: 23355260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
    Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
    BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
    Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review.
    Lacreta G; Bucharles SGE; Sevignani G; Riella MC; Nascimento MMD
    J Bras Nefrol; 2019; 41(1):145-151. PubMed ID: 30160771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Hashimoto K; Harada M; Kamijo Y
    Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation.
    Chen XM; Li H; Wu Y; Wang LL; Bai YJ; Shi YY
    Front Immunol; 2022; 13():1049444. PubMed ID: 36524109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple immunosuppressive therapy can accelerate the recovery of antibody-mediated pure red cell aplasia and allow successful concurrent resumption of erythropoietin.
    Ruangkanchanasetr P; Srichaikul T; Supaporn T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S92-5. PubMed ID: 22934452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure.
    Shinohara K; Mitani N; Miyazaki M; Sakuragi S; Matsuda K; Ogawara S; Saito T; Kaneoka H; Ooji T
    Am J Hematol; 2005 Jan; 78(1):15-20. PubMed ID: 15609276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.
    Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P
    Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
    Katagiri D; Shibata M; Katsuki T; Masumoto S; Katsuma A; Minami E; Hoshino T; Inoue T; Tada M; Hinoshita F
    Clin Exp Nephrol; 2010 Oct; 14(5):501-5. PubMed ID: 20652821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature.
    Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(5):2624-35. PubMed ID: 24966977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis.
    Li S; Chen X; Hu P; Wu S; Ma J; Li Z; Wu X; Wen F; Fu X; Feng Z; Tao Y; Li B; Fu L; Huang R; He C; Shi W; Liang X; Liu S
    Blood Purif; 2022; 51(2):189-192. PubMed ID: 34500449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
    Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
    J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
    Janda K; Kraśniak A; Krzanowski M; Sułowicz W
    Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
    Casadevall N
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from pure red cell aplasia caused by anti-erythropoietin antibodies after kidney transplantation.
    Snanoudj R; Beaudreuil S; Arzouk N; Jacq D; Casadevall N; Charpentier B; Durrbach A
    Am J Transplant; 2004 Feb; 4(2):274-7. PubMed ID: 14974951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.